Teratoma formation: A tool for monitoring pluripotency in …

References 1.. Discher, DE. Mooney, DJ. Zandstra, PW. Growth factors, matrices, and forces combine and control stem cells. Science (2009). 26324(5935), 16731677. Article Abstract 2.. Sato, N. Meijer, L. Skaltsounis, L. et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med (2004). 10(1), 5563. Article Abstract 3.. Schuldiner, M. Yanuka, O. Itskovitz-Eldor, J. et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 10 (2000). 97(21), 1130711312. Article Abstract 4.. Xu, C. Rosler, E. Jiang, J. et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells (2005). 23(3), 315323. Article Abstract 5.. Herszfeld, D. Wolvetang, E. Langton-Bunker, E. et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol (2006). 24(3), 351357. Article Abstract 6.. Laflamme, MA. Chen, KY. Naumova, AV. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007). 25(9), 10151024. Article Abstract 7.. Lombardo, A. Genovese, P. Beausejour, CM. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol (2007). 25(11), 12981306. Article Abstract 8.. Lebkowski, JS. Gold, J. Xu, C. et al. Human embryonic stem cells: culture, differentiation, and genetic modification for regenerative medicine applications. Cancer J (2001). 7(Suppl 2), S83S93. Abstract 9.. Zou, J. Maeder, ML. Mali, P. et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell (2009). 25(1), 97110. Article Abstract 10.. Gropp, M. Itsykson, P. Singer, O. et al. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther (2003). 7(2), 281287. Article Abstract 11.. Kooreman, NG. Wu, JC. Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface (2010). 7(Suppl 6), S753S763. Article Abstract

12.. Cao, F. Drukker, M. Lin, S. Molecular imaging of embryonic stem cell misbehavior and suicide gene ablationCloning Stem Cells 2007 Spring; 91107117 [doi: 10.1089/clo.2006.0E16] [pmid: 17386018]

25.. Geron Corporation. . 2010Geron's IND for Spinal Cord Injury Placed on Hold [Press release] Retrieved from http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-newsArticle&ID=1636249&highlight=

26.. Johnson, S. 2010FDA approves Geron's groundbreaking study of embryonic cellsSan Jose Mercury News. Retrieved from http://www.geneticsandsociety.org/article.php?id=5305

43.. Fischer, AH. Jacobson, KA. Rose, J. Paraffin embedding tissue samples for sectioningCSH Protoc 2008 1:pdb.prot4989. [doi: 10.1101/pdb.prot4989] [pmid: 21356832]

44.. Fischer, AH. Jacobson, KA. Rose, J. Cutting sections of paraffin-embedded tissuesCSH Protoc 2008 1:pdb.prot4987. [doi: 10.1101/pdb.prot4987] [pmid: 21356830]

Here is the original post:

Teratoma formation: A tool for monitoring pluripotency in ...